. 2015 Jul 30;23(2):283–288. doi: 10.1093/jamia/ocv067

Table 2:

Favorability frequency

Recommended continuous IV insulin infusion rate at time = t _i^a	Blood Glucose category (mg/dL) at time = t _i_{+ 1}^a	Favorability frequency, n (%)
	Blood Glucose category (mg/dL) at time = t _i_{+ 1}^a	eProtocol-insulin	Glucosafe	Equivalent
	<80	273 (15)	1470 (80)	102 (5)
a (continuous IV insulin infusion rate recommendations = ) ^a	80–110	2919 (31)	5984 (64)	453 (5)
b (continuous IV insulin infusion rate recommendations ± 10%) ^a	80–110	2483 (26)	5573 (60)	1300 (14)
	>110	2045 (26)	5473 (70)	265 (4)

Counts of more favorable continuous IV insulin infusion rate recommendations at time = t _i from eProtocol-insulin or Glucosafe, based on three blood glucose categories at time = t _i_{+ 1} .

^a Analysis (a) in Figure 1 (continuous IV insulin infusion rate recommendations of eProtocol-insulin and Glucosafe are equivalent only when they are equal). Analysis (b) in Figure 1 (continuous IV insulin infusion rate recommendations of eProtocol-insulin and Glucosafe are equivalent when they are within 10% of the lower continuous IV insulin infusion rate recommendation (±10%, b in Figure 2 ).